Ruli Ge
Binzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Lnc-USP28-6/ZBTB16 axis orchestrates NLRP3 inflammasome activation and α-synuclein SUMOylation to drive Parkinson's disease pathogenesis.
Journal: Brain, behavior, and immunity
Published: August 02, 2025
AS-IV attenuates nigral NLRP3 inflammasome in a Parkinson's disease mouse model via gut microbiota.
Journal: Communications biology
Published: May 31, 2025
Stereotactic infusion of rotenone into the SN induced a late-stage model of Parkinson's disease.
Journal: Experimental neurology
Published: October 07, 2024
Microglia in the context of multiple sclerosis.
Journal: Frontiers in neurology
Published: February 02, 2023
A case report of Parkinson's disease with acute and unmanageable myoclonic dyskinesia.
Journal: Clinical neurology and neurosurgery
Published: May 05, 2022
Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson's Disease.
Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson's Disease.
Journal: Frontiers in molecular biosciences
Published: March 30, 2022
Follicular Helper CD4+ T Cells, Follicular Regulatory CD4+ T Cells, and Inducible Costimulator and Their Roles in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Journal: Mediators of inflammation
Published: April 28, 2021
Protective effect of roscovitine against rotenone-induced parkinsonism.
Journal: Restorative neurology and neuroscience
Published: July 30, 2018
P75 Involved in the Ubiquitination of α-synuclein in Rotenone-based Parkinson's Disease Models.
Journal: Neuroscience
Published: February 24, 2018
Hearing Improvement in A/J Mice via the Mouse Nerve Growth Factor.
Journal: Clinical and experimental otorhinolaryngology
Published: October 02, 2016
Last Updated: 09/26/2026